Purpose: Bone marrow response to an organismal stress is made by orchestrating the interplay between hematopoietic stem/progenitor cells (HSPCs) and mesenchymal stromal cells (MSCs). Neither the cellular nor the molecular factors that regulate this process are fully understood, especially since this mechanism probably varies depending on the type of stress. Herein, we explored the differentiation and fate of MSCs and HSPCs in mice challenged with a hematopoietic stress or a mechanical stress applied separately or in combination. Methods: Mice were subjected to 4 days of hypobaric hypoxia (hematopoietic challenge) and/or 7 days of hindlimb suspension (stromal challenge) and then sacrificed for blood and bone collection. Using hematological measurements, colony-forming unit assays, bone histomorphometry and array-based multiplex ELISA analysis, we evaluated challenge influences on both MSC and HSPC mobilization, differentiation (osteoblasts, osteoclasts, and mature blood cells) and fate. Results: We found that hypoxia leads to HSPC mobilization and that an imbalance between bone formation and bone resorption accounts for this mobilization. Whilst suspension is also associated with an imbalance between bone formation and bone resorption, it does not induce HSPC mobilization. Then, we revealed cellular interactions by combining hematopoietic and stromal challenges together in mice. We showed that the hypoxia-driven HSPC mobilization is moderated by suspension. Moreover, when applied in a hypoxic environment, suspension offsets bone imbalance. We identified stroma cell-derived factors MIP-1α, HGF and SDF-1 as potent molecular key players sustaining interactions between hindlimb suspension and hypobaric hypoxia. Conclusion: Taken together, our data highlight the benefit of combining different types of stress to better understand the interplay between MSCs and HSPCs.
Introduction
Musculoskeletal and hematopoietic systems display great plasticity and are both able to adapt in response to changes in work demand. Coordinated response to environmental stress is made, at least in part, by the interplay between mesenchymal stromal cells (MSCs) and hematopoietic stem and progenitor cells (HSPCs) in bone marrow (BM) niches. For instance, in oncology, administration of the hematopoietic cytokine granulocyte-colony stimulating factor (G-CSF) induces HSPC mobilization from bone marrow leading to MSC pool expansion as a consequence of the G-CSF-driven increased bone turnover. 1 In high altitude environments, a well-known standard physiological adaptation to hypobaric hypoxia is the increase in red blood cell production. 2 At the BM level, fine physiological adjustments are made to enhance both erythroid progenitor proliferation and maturation. This process is likely to be orchestrated by the hematopoietic cytokine erythropoietin (EPO), whose production is increased by hypoxia. Beyond its hematopoietic function, a growing body of evidences suggest that EPO might also have a direct action on mesenchymal lineage cells in vivo. 3 This view is sustained by some studies reporting that bone development is impaired at high altitude and that chronic long-term hypobaric hypoxia might be a potent bone loss trigger. 4, 5 However, whether these observations are a consequence of the hematopoietic adaptation to altitude or whether it results from a direct action of the hypoxia signaling on bone cells remains under debate.
What is however well documented is bone cell adaptation to suspension. 6 Long-term exposure to a weightlessness space environment causes astronaut bone loss. 7 Due to the limited spaceflight opportunities, the hindlimb unloading model, also known as the hindlimb suspension model, was developed in rodents as a ground-based model of weightlessness to investigate the underlying mechanisms leading to bone loss. 8 Our team and others reported that bone mass reduction in hindlimb suspended mice is related to a sustained decrease in MSC number and osteoblast differentiation, altogether with a transient increase in the number of HSPC-derived osteoclasts. [9] [10] [11] Aside from bone loss, widespread alterations in the hematopoietic system have been reported after exposure to microgravity and hindlimb suspension, including decreased differentiation of white blood cells from hematopoietic precursors and reduction in red blood cell mass. 12, 13 Due to the aforementioned observations, we sought to take advantage of interactions between hypoxia (hematopoietic stress) and suspension (stromal stress), speculating that combination of both stressors might be relevant to reveal biological synergies or antisynergies leading to a better knowledge of HSPC and MSC maintenance. In other words, our assumption was that stromal and hematopoietic challenges applied separately can both modulate either positively or negatively stem and progenitor cell maintenance, but when applied together one can superimpose or oppose its effects on the other one. Moreover, with the recent focus on deep space exploration and ultimately the shift toward manned planetary exploration to Mars, there is a need for space medicine to assess the combined effects of microgravity-induced unloading and hypoxia on hematological and musculoskeletal functions since future space habitats are expected to cumulate both microgravity drawbacks and reduced PO 2 atmosphere.
14 In this context, the very recent PlanHab (Planetary Habitat Simulation) project sought to address the separate and combined effects of hypoxia and sustained recumbency (bedrest) on human physiological systems, including both the hematopoietic and musculoskeletal ones. 15, 16 In the blood of PlanHab volunteers, an interesting finding was the increase in EPO level under hypoxic conditions and the EPO level reduction induced by bed-rest confinement. In bedridden patients exposed to hypoxia, investigators showed that hypoxia prevents the bed restdriven EPO decrease.
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Regarding bone metabolism, PlanHab findings were rather surprising because the study refutes the expected idea of modulatory effects by hypoxia upon bed restinduced bone loss. 15 However, it is noteworthy that PlanHab study did not examine interactions between hematopoietic and stromal stresses at the bone marrow level. Yet, it can be assumed that any interactions between reduced gravity and low inspired PO 2 regarding hematologic and musculoskeletal responses will be easier to reveal in the bone marrow compartment, where both MSCs and HSPCs reside.
Therefore, the aim of the present study was to examine the differentiation and fate of MSCs and HSPCs in both bone marrow compartment and blood of mice subjected to hindlimb suspension and hypoxia applied either separately or in combination. As expected, adding hypoxia to suspension revealed interactions not only at the cellular level on HSPC and MSC mobilization and differentiation but also at the molecular level on key regulator factors of BM niches. In parallel, this work also revealed that hematopoietic stress-induced HSPC mobilization is related to an imbalance between bone formation and bone resorption whereas stromal stress-induced imbalance between bone formation and bone resorption is not necessarily linked to HSPC mobilization. These findings suggest that different pathways are involved in these physiological responses.
Materials and methods

Animal care
Ten-week-old male C57BL/6J mice (Janvier labs, Le GenestSaint-Isle, France) were individually housed under standard 
Experimental protocol
Mice were randomly assigned to 4 experimental groups (n=10 per experimental group) as described in Figure 1 . At D 0 , half mice population were placed into hindlimb suspension cages for 7 days, following the procedure previously described by Holy et al. 17 In this model, the hindlimbs of rodents are elevated with an unloading device to produce a 30-35°head-down tilt angle, which avoids weight-bearing by the hindquarters. At the third day of suspension, the suspended mice were equally separated into 2 groups. One group was kept under normoxic conditions at 101 kPa (NS group; FiO 2 =21%) while the other group of suspended mice was housed for 4 days into a hypoxic chamber at 50 kPa (HS group, FiO 2 =10%). The remaining half unsuspended mice population was either housed in normoxic conditions for all the experiment duration (NC group) or was exposed to hypobaric hypoxia for the last 4 days of the experiment (HC group). Of note, suspension and hypoxia onset times were delayed by a 3-day gap for ethical reasons. Since both stresses are classified as severe procedures, we did not want to initiate these two procedures simultaneously. In a preliminary investigation, we previously validated hematologic and bone metabolism changes induced by both suspension and hypoxia environmental conditions as well as stress durations. 18 All animals were sacrificed under isoflurane anesthesia at D 7 for blood (intracardiac puncture) and femur collections.
Hematological measurements
Blood was collected through intra-cardiac puncture with 3.8% citrate w/v to avoid blood clotting. Hematological measurements were performed using the MS-9 automatic hematology analyzer (Melet Schloesing Laboratoires, Osny, France) with mouse-specific analysis software.
Colony-forming unit (CFU) assays
HSPCs were quantified by CFU assay in the BM and blood, as previously described. 18 Hematopoietic colonies were classified according to standardized morphologic criteria as erythroid progenitors (burst-forming unit-erythroid BFU-E) and myeloid-derived progenitors including CFUgranulocyte (CFU-G), CFU-macrophage (CFU-M) and CFU-granulocyte macrophage (CFU-GM). Freshly isolated BM cells from the same femurs were also evaluated for MSC colony forming unit-fibroblast (CFU-F) assay as previously described. 18 Giemsa-stained adherent colonies (>50 cells) deriving from MSCs were counted on days 12-14.
Histomorphometry
One-day formaldehyde-fixed femurs were successively dehydrated in ethanol and xylene, and then embedded in Technovit ® resin. Five-micrometer longitudinal sections were prepared and stained with Masson-Goldner trichrome 
(iv) Figure 1 Experimental set-up. Mice were randomly assigned to 4 different experimental groups (n=10 mice per group): (i) Normoxic control (NC) group: mice were kept under normoxic conditions (FiO 2 =21%) from day 0 to the day of sacrifice (day 7); (ii) Normoxic suspended (NS) group: mice were subjected to suspension from day 0 to day 7 under normoxic conditions (FiO 2 =21%); (iii) Hypoxic control (HC) group: mice were housed into a hypoxic chamber at 50 kPa (FiO 2 =10%) for 4 days before sacrifice (day 3 to day 7); (iv) Hypoxic suspended (HS) group: mice were subjected to suspension for 7 days (day 0 to day 7) and were transferred into a hypoxic chamber at 50 kPa (FiO 2 =10%) for the 4 final days of suspension (day 3 to day 7).
dye. Static bone histomorphometric parameters (osteoblast surface normalized to bone surface Ob.S/BS, osteoclast number normalized to bone surface Oc.N/BS and bone volume/total volume ratio BV/TV) in the secondary metaphyseal area were measured using a Leica Aristoplan microscope under blind conditions. Histomorphometric parameter values were measured in three different nonadjacent sections and averaged.
Protein analysis in BM supernatant and blood plasma
Levels of different proteins involved in stem cell niche maintenance and progenitor commitment were determined in supernatant of femoral BM flushes using an array-based multiplex sandwich Elisa from RayBiotech (RayBiotech Life, Norcross, GA, USA). Briefly, femurs were flushed with a syringe (26 gauge needle) containing 500 µL IMDM +1% penicillin-streptomycin-neomycin antibiotic mixture and then BM flushes were centrifuged for 10 mins at 350 g and +4°C. The resulting supernatants were used for protein analysis. Supernatant samples (50 µL) were loaded onto array slides designed with implanted capture antibodies raised against insulin-like growth factor-1 (IGF-1), vascular endothelial growth factor (VEGF), hepatocyte growth factor (HGF), macrophage inflammatory protein-1α (MIP-1α). Fluorescence-based quantification was performed by incubating array slides with HyLite plusTM555-labeled detection antibody and by laser scanner reading with an Agilent G2505B microarray scanning device and Q-analyzer software analysis. This proteome analysis experiment was subcontracted by Tebu-Bio (Tebu-Bio, Le Perray-en-Yvelines, France). SDF-1 (stromal cell-derived factor-1) concentration was assessed by Quantikine enzyme-linked immunosorbent assay following manufacturer's instructions (MCX120 kit, R&D Systems, Minneapolis, MN, USA) and EPO concentration was measured in plasma using the mouse EPO enzymelinked ELISA kit (MEP00B kit; R&D Systems, Minneapolis, MN, USA).
Data analysis
A two-way analysis of variance (ANOVA) was used to elucidate the effects of hypoxia and suspension and their possible interactions (hypoxiaxsuspension) on the outcomes. When interactions in the two-way ANOVA were statistically significant, pairwise comparisons were investigated using Newman Keuls post-hoc test. Whenever interaction was not significant, main effect of hypoxia or suspension was thus reported. Results of statistical tests with p≤0.05 were considered significant (Statview software, SAS Institute Inc., Cary, NC, USA). All data are expressed as mean±standard deviation (SD).
Results
Suspension alters the hypoxia-induced egress of HSPCs from BM to blood
We first analyzed the consequence of suspension added onto a hematopoietic stress, namely hypoxia, on the BM hematopoietic progenitor compartment. As shown in Figure 2A , ANOVA underscored a significant effect of hypoxia (p≤0.001) by decreasing the number of myeloidderived progenitors (CFU-G+CFU-GM+CFU-M) in BM, without any influence of suspension (no hypoxiaxsuspension interaction). Conversely, a significant interaction was found for erythroid progenitors (BFU-E) ( Figure 2C ). Indeed, hypoxia decreased the BM pool of BFU-E by 86% in control animals (NC group vs HC group) and suspension decreased it by 55% in normoxic mice (NS group vs NC group). However, suspension added onto hypoxia did not lead to a further BFU-E pool reduction, indicating that suspension and hypoxia do not superimpose their effects. Then, we studied whether the medullar depletion of the HSPCs coincided with their mobilization into the peripheral blood. A significant hypoxiaxsuspension interaction (p<0.05) was found for both myeloid and erythroid progenitor cell numbers in blood ( Figure 2B and D). Post-hoc comparisons revealed that hypoxia produced a different effect whether the animals were suspended or not. Hypoxia increased the number of erythroid and myeloid progenitors in control animal blood (NC vs HC) by +97% and +92%, respectively. No significant difference was evidenced between NS and HS groups, suggesting that suspension prevents the hypoxia-driven mobilization of hematopoietic progenitor cells in blood.
Suspension does not alter hypoxia-driven hematological changes
In peripheral blood samples, ANOVA indicated a main hypoxia effect on blood formulation, without any influence of suspension or hypoxiaxsuspension interaction ( Table 1) . As expected, four days of hypoxia led to a massive rise in reticulocyte counts (+260.7%) and significant increases in hematocrit (+18.4%), hemoglobin rate (+18.3%) and red blood cell counts (+14.2%). Hypoxia effects were not restricted to the erythroid lineage, since a 2-fold increase in the white blood cell counts of hypoxic mice was evidenced compared to normoxic mice, mainly involving monocyte increase (+63.8% rise).
Hypoxia modulates bone cell responses to suspension, without altering the suspension-driven bone loss
We then investigated the consequence of hypoxia added onto a stromal stress, namely suspension, on bone metabolism. As shown in Figure 3A , ANOVA yielded a hypoxiaxsuspension interaction (p<0.01) for the number of MSC/ osteoprogenitors assayed by CFU-F in BM. Post-hoc comparison revealed that suspension significantly decreased by 1.7-fold the osteoprogenitor pool in normoxic mice (NS group vs NC group). Moreover, hypoxia significantly decreased by 2.5-fold the quantity of MSC/osteoprogenitors (CFU-F-colonies) in control animals (NC group vs HC group). However, the pool of CFU-F in suspended animals was not significantly decreased by hypoxia (HS group vs HC and NS groups), indicating that suspension and hypoxia do not superimpose their effects. We next asked the effects of suspension and hypoxia on MSCderived bone-forming osteoblasts ( Figure 3B and E). ANOVA yielded a significant hypoxiaxsuspension interaction (p<0.01) for the metaphyseal Ob.S/BS. Likewise with the CFU-F data, post-hoc comparison revealed that the osteoblast surface was decreased by hypoxia in control animals (−50%) and by suspension in normoxic animals (−34%). However, osteoblast surface in HS animals was significantly not different when compared with HC and NS mice, also showing that suspension and hypoxia do not superimpose their effects. Regarding the bone-resorbing osteoclasts, deriving from the monocyte/macrophage hematopoietic lineage, a significant hypoxiaxsuspension interaction (p<0.05) was found, as shown in Figure 3C . In control animals (NC vs HC), hypoxia drastically increased Oc.N/BS by 2.0 fold ( Figure 3F ). While suspension also increased Oc.N/BS in the normoxic environment (NC vs NS animals), the suspension-triggered rise was canceled out in the hypoxic environment (HC vs HS). Changes in bone mass representing the effect of both bone formation and bone resorption, thereby we examined trabecular bone volume fractions (BV/TV, Figure 3D ). A main suspension effect (p<0.05) was detected for this parameter without hypoxiaxsuspension interaction, although such an interaction was noticed for both Ob.S/ BS and Oc.N/BS.
Suspension and hypoxia interact at the molecular level
To initiate understanding in underlying mechanisms contributing to the different interactions seen at the BM level, cytokine multiplex analysis was performed in our mice BM supernatants. We focused on molecular factors known to be involved in the regulation of hematopoiesis or bone metabolism into the BM environment. In addition, these molecules have previously been shown to be impacted by hypoxia and suspension in mice bearing bone defect. 18 Interestingly, different patterns of changes were detected upon hypoxia and suspension challenges, as shown in Figure 4 . The levels of IGF-1 and VEGF in the BM supernatants were significantly downregulated (p<0.01 and p<0.001 for IGF-1 and VEGF, respectively) by the hypoxic challenge (NC+NS vs HC+HS groups). Neither effect of suspension nor hypoxiaxsuspension interaction was revealed on these cytokine levels. By contrast, a significant interaction between hypoxia and suspension was evidenced for other factors such as HGF (p<0.01), SDF-1 (p<0.01) and MIP-1α (p<0.05). HGF level in BM supernatants is significantly decreased by 55% by hypoxia in control animals (NC group vs HC group) and by 60% by suspension in normoxic mice (NS group vs NC group). However, in suspended animals, additional hypoxia failed to decrease even more the level of HGF (HS group vs NS group). MIP-1α was decreased by hypoxia (−56%) in control animals only (NC vs HC) but not in suspended ones (NS vs HS). SDF-1 level was found to be reduced under suspension in the normoxic context (NS vs NC) and also under hypoxia in control animals (NC vs HC), without any additive effect when both suspension and hypoxia were combined. Aside from these BM quantifications, we also investigated the plasmatic level of erythropoietin (Epo) and found a main effect of hypoxia in the Epo concentration (+382% increase under hypoxia).
Discussion
In this study, we aimed at exploring MSC and HSPC maintenance as well as their further fate under hematopoietic and stromal challenges. To this end, we used a two level factorial protocol to assess 1) the hematopoietic stress effects per se (hypobaric hypoxia), 2) the stromal stress effects per se (hindlimb suspension) and 3) the combined effects of both challenges.
Responses to hematopoietic challenge per se: hypoxia applied alone without any suspension challenge
As expected, the most salient feature of low oxygen exposure, namely the hypoxia-induced rise in plasmatic EPO level, was recapitulated in this study. Concomitantly, marked increased hematocrit, hemoglobin rate and red blood cell counts were observed. Although this polycythemic response to hypoxia was expected, the magnitude and the rapid onset of the response after only four days of hypoxic exposure were striking. Presumably, hypoxia-driven polycythemia in our hypoxic animals was intensified by the increased diuresis and reduced plasma proteins usually observed under high-altitude exposure and thus leading to an isotonic hypovolemia. 19 These profound hematological changes were accompanied by a depletion of the erythroid progenitor pool in BM and its concomitant expansion in the blood microenvironment, suggesting the mobilization of BFU-E progenitors from the BM to the blood circulation. In keeping with this mobilization, SDF-1, a critical regulator of HSPC Figure 4 Suspension and hypoxia interact at the molecular level. In BM supernatants, level of proteins involved in stem cell proliferation and mobilization such as (A) IGF-1 (insulin-like growth factor-1), (B) VEGF (vascular endothelial growth factor), (C) HGF (hepatocyte growth factor), (D) MIP-1α (macrophage inflammatory protein-1α), and (E) SDF-1 (stromal cell-derived factor-1) was determined using Multiplex Sandwich Elisa (n=5/group) or Elisa kit (for SDF-1 only, n=10/group). In panel F, plasmatic level of Epo (erythropoietin) was measured by Elisa kit (n=5/group). *p≤0.05, **p≤0.01 and ***p≤0.001.
interactions with the osteoblastic niche and a key stem cell mobilizer, was downregulated by hypoxia in the BM. 20 Regarding bone metabolism, the expectation that hypoxia exposure would hamper osteoblastogenesis is supported by our results, since decreases in CFU-F pool, Ob.S/BS and BM level of pro-osteoblastic factors IGF-1 and HGF were observed under hypoxia. 21, 22 Despite the BM level reduction in pre-osteoclastic factor MIP-1α, the Oc.N/BS increase observed in our hypoxic mice supported previous reports suggesting that in vitro hypoxia triggers osteoclastogenesis. 23, 24 Given the hypoxia-induced increase in bone-resorptive osteoclasts and decrease in bone-forming osteoblasts on trabecular bone surfaces, one would expect a reduced trabecular bone volume fraction in our hypoxic mice. Much to our surprise, we did not observe any bone loss in HC animals when compared to NC littermates. A likely explanation to this result might be changes in bone cell activity or that a 4-day hypoxic exposure is not long enough to induce significant changes in bone structure, despite visible changes at bone cell level. Consistently with our results, recent finding from the Plan Hab study also suggests that 21 days of hypoxia in healthy humans do not trigger bone loss. 15 Likewise, Wang et al report that a 14-day hypoxic exposure does not appear to affect trabecular bone structure and volume in healthy rats. 25 Thus, whether or not systemic hypoxia exposure drives bone loss is not clear. Another unexpected result was the hypoxia-induced decrease in BM VEGF level. Indeed, hypoxia is known to be a stimulatory factor for VEGF expression in vivo and exposing mice to systemic hypoxia leads to VEGF induction in brain, testis, lung, heart and liver. But conversely, cells at sites of constitutive VEGF expression in normal adult tissues, such as epithelial cells in the choroid plexus and kidney glomeruli, decrease their VEGF expression in response to a systemic hypoxic stimulus. 26 Since the BM is an established site of constitutive VEGF expression, it is therefore not that surprising to observe in this study a VEGF reduction under hypoxic challenge.
Responses to stromal challenge per se: suspension applied alone without any hypoxic challenge
The most salient features of suspension-related bone metabolism changes were recapitulated in this study, namely bone loss resulting from a decreased level of bone-forming osteoblasts along with an increased level of bone-resorbing osteoclasts. 11, [27] [28] [29] [30] [31] In keeping with the decreased Ob.S/BS, reductions in the osteoprogenitor pool (CFU-F) and BM level of pro-osteoblastic factor HGF were observed under suspension challenge. By contrast, BM IGF-1 level remained unchanged under suspension, although this cytokine may be involved in the process of suspension-related bone loss as previously described. 32 Regarding hematopoiesis, our findings indicated that suspension reduced the BM level of the hematopoietic stem cell mobilizer factor SDF-1/CXCL-12, in line with previous study. 33 Moreover, suspension also significantly decreased BFU-E pool size. This reduction in the BM did not coincide with an expansion of the BFU-E progenitors neither in blood or spleen (data not shown in spleen). Alternatively, blood parameters were not affected by suspension despite a faint however not significant decline in red blood cell count and hematocrit. Taken together, these findings suggest that the BM depletion of erythroid progenitors was not related to BFU-E mobilization from BM to blood, but more likely to an underlying anemia which had not yet led to any apparent modification at the blood level by the time of the sacrifice. Indeed, previous report from MoreyHolton indicates that hindlimb suspension in rodents is associated with erythropoiesis inhibition which may result from lowered oxygen requirements due to musculoskeletal unloading. 8 Lack of suspension effect on the myeloid progenitors in the BM, blood and spleen (data not shown in spleen) reinforced the view that suspension did not trigger HSPC mobilization. 8 Taken together, our results presented earlier showed that when applied separately both suspension and hypoxic challenges led to bone imbalance caused by an increase in bone-resorbing osteoclasts and a decrease in bone-forming osteoblasts. Though, only the hypoxia-driven bone imbalance appeared to be associated with HSPC mobilization from BM to blood.
Combined effects of hypoxia and suspension
Previous results from the Plan Hab study in humans refute the idea of a strong modulatory effect of hypoxia on disuse-driven bone loss. 15 In line with this, we found that the suspension-driven loss in bone volume fraction (BV/ TV) was not impacted by hypoxia. Likewise, changes in hematological parameters in response to hypoxia were not influenced by suspension challenge. However, at the BM level, modulatory effects of interaction between hypoxia and suspension were detected as hypothesized on different cell populations, including BFU-E progenitors. Indeed, our data indicated that suspension compromised the hypoxiatriggered egress of erythroid progenitors from BM to blood. Given the underpinning anemia detected in the suspension group, it is likely that suspended animals have a smaller BFU-E pool available for mobilization when exposed to delayed hypoxia compared to their control littermates. Interactions were also detected on osteoclast and osteoblast numbers. Indeed, either hypoxic stress or suspension alone could lead to bone imbalance, but combination of both challenges did not exacerbate bone imbalance. Such similar observations were made on osteoprogenitors (CFU-F) and BM level of both HGF and SDF-1 since we found that the effects of hypoxia and suspension on these parameters did not superimpose each other. Altogether, these lines of evidence may suggest that hypoxia and suspension impact different signaling pathways in the BM. As such, these results are compatible with the current view that BM environment is a highly complex, integrated ensemble of multiple microniches and subtypes of stromal cells each specialized in unique hematopoietic functions and responding differently to stress or injuries. 34, 35 Another key regulatory component in BM niches is the sympathetic nervous system (SNS), which not only regulates physiological homeostatic trafficking of HSPCs but also enables them to respond to acute stress signals. [36] [37] [38] Hypoxia is a potent activator of sympathetic nervous tone, while SNS is also involved in suspensioninduced bone loss. 39, 40 Thus, in our study, it is more likely that suspension and hypoxia responses share signaling pathways, but when both challenges were combined, response amplifications were limited due to physiological thresholds in cellular and molecular parameters. We are aware that some limitations need to be addressed in our study. First, the onset of the hypoxic episode was delayed by 3 days from the onset of the suspension challenge. This was done for ethical reasons, since we avoided initiating severe procedures simultaneously on mice. Delaying the onsets implies that BM microenvironments were altered by 3 days of suspension prior to triggering the hematopoietic challenge. Findings might have been different upon simultaneous induction of suspension and hypoxia. For instance, suspended mice exposed to delayed hypoxia would not have displayed underlying anemia. Therefore, one could guess that HSPC mobilization would have been less impaired compared to non-suspended hypoxic littermates. Second, it is well documented that the main characteristic of calcium metabolism during spaceflight and in the rodent suspension model is negative calcium balance. 28, [41] [42] [43] On another note, hypoxia-induced hyperventilation leads to a further deregulation of acid/base homeostasis and changes in serum calcium. 44, 45 Based on these elements, it would have been interesting to assess interferences in calcium and acid/base balances in this study especially since strong modulation of calcium homeostasis by hypoxia was found in the PlanHab study. 15 The study described herein is part of a bone repair study in which animals bearing a drill-hole bone defect were exposed to the same experimental set-up combining suspension and delayed hypoxia. 18 Hypoxia is one of the main trigger of Epo expression. 3 Consistently, mice challenged with hypoxia in both our present and previous studies displayed high plasmatic levels of EPO. Most recent works point toward a context-dependent role for EPO in the skeletal system. In atraumatic animal models, a bone catabolic effect of EPO is reported. 46 High plasmatic levels of EPO are associated with a severe trabecular bone loss due to increased bone resorption and decreased bone formation. [47] [48] [49] In contrast, EPO treatment has a bone anabolic effect in animal models of bone regeneration. [50] [51] [52] As discussed earlier, the present study highlighted a catabolic role for hypoxia in bone homeostasis. In a tissue healing context, our previous work showed that a 4-day episode of hypoxia accelerates the healing of a femoral defect. Interestingly, suspension failed to impact the hypoxia-driven enhanced bone repair indicating that hypoxia superimposed its effect on suspension-induced bone resorption. Taken together, our studies support the assumption of a context-dependent mode of action of Epo on bone physiology, playing opposite skeletal actions during traumatic bone regeneration and steady-state bone remodeling. As such, further studies are warranted to decipher the dual role of EPO on bone metabolism and repair.
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